NCT04095351View on ClinicalTrials.gov

Connective Tissue Diseases and Lung Manifestations

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 9, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

October 1, 2034

Conditions
Connective Tissue DiseasesInterstitial Lung DiseaseSystemic Sclerosis
Interventions
DIAGNOSTIC_TEST

Pulmonary function test

Spirometry or plethysmography, measurement of diffusion capacity

DIAGNOSTIC_TEST

Imaging

Thoracic ultrasound, HRCT as scheduled within routine clinical examinations, echocardiography

BIOLOGICAL

Blood sampling

Standard laboratory test for CTDs as part of routine clinical examination

Trial Locations (1)

6020

RECRUITING

Medical University Innsbruck, Department of Internal Medicine II, Innsbruck

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Medical University Innsbruck

OTHER

NCT04095351 - Connective Tissue Diseases and Lung Manifestations | Biotech Hunter | Biotech Hunter